๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Adult Burkitt Lymphoma

Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia NCT06581081NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Senl_B19 autologous CAR-T (S1904) treatment Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia NCT03136146Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bortezomib, Clofarabine, Cyclophosphamide, Dexamethasone, Etoposide Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies NCT07523555Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: Autologous CD19/CD22 dual-target CAR-T module, Autologous CD19/CD20 dual-target CAR-T module, Autologous BCMA/CD19 dualโ€ฆ Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies NCT07648264Phase 360 sites๐Ÿ“ Orange๐Ÿ“ Denver๐Ÿ“ Coral Springs CSL Behring ยท Tests: IgPro20 A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) NCT06124157Phase 2161 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Tucson National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Biopsy, Calaspargase Pegol, Cyclophosphamide Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801n/a6 sites๐Ÿ“ Aurora๐Ÿ“ Atlanta๐Ÿ“ Cincinnati Children's Hospital Medical Center, Cincinnati ยท Tests: 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid)โ€ฆ Study of Out of Specification for Tisagenlecleucel NCT04094311Phase 355 sites๐Ÿ“ Hamilton๐Ÿ“ Ottawa๐Ÿ“ Toronto Novartis Pharmaceuticals ยท Tests: CTL019 The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL NCT03509961Phase 224 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Duarte Pediatric Transplantation & Cellular Therapy Consortium ยท Tests: NGS-MRD, Myeloablative allogeneic HCT with a non-TBI conditioning regimen Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders NCT03314974Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: HSCT with TBI Regimen, HSCT with Non-TBI Regimen REal World Data in LYmphoma and Survival in Adults NCT03869619n/a37 sites๐Ÿ“ Arras๐Ÿ“ Besanรงon๐Ÿ“ Bordeaux Hospices Civils de Lyon ยท Tests: Real-life epidemiological platform of lymphoma in France Registry of Older Patients With Cancer NCT01137825n/a7 sites๐Ÿ“ Boone๐Ÿ“ Chapel Hill๐Ÿ“ Greenville UNC Lineberger Comprehensive Cancer Center A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia NCT07205315EARLY Phase 12 sites๐Ÿ“ Zhengzhou๐Ÿ“ Tianjin Grit Biotechnology ยท Tests: GT801 Injection CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol NCT05648019Phase 22 sites๐Ÿ“ Singapore๐Ÿ“ Singapore KK Women's and Children's Hospital ยท Tests: Anti-CD19 CAR T-cells Toxicity of Intensive First-Line Treatment for Adult Burkitt Lymphoma: A Retrospective Observational Study NCT07895927n/a1 site๐Ÿ“ Strasbourg University Hospital, Strasbourg, France Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia NCT02877303Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Blinatumomab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL) NCT06785324NA1 site๐Ÿ“ Chicago University of Chicago ยท Tests: Nutrition Intervention, Exercise intervention AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia NCT06137118Phase 1, Phase 283 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Los Angeles AstraZeneca ยท Tests: Surovatamig Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence NCT05310591Phase 1, Phase 213 sites๐Ÿ“ Bordeaux๐Ÿ“ Lille๐Ÿ“ Lyon Assistance Publique - Hรดpitaux de Paris ยท Tests: Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) ), Nivolumab โ€ฆ Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia NCT03150693Phase 3460 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Anchorage Alliance for Clinical Trials in Oncology ยท Tests: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas NCT06340737Phase 11 site๐Ÿ“ Palo Alto Stanford University ยท Tests: CD22CART Infusion Allogeneic CD19-targeted CAR-ฮณฮดT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia NCT06696833EARLY Phase 11 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: QH10304-BAL-01, Fludarabine, Cyclophosphamide Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma NCT06918431Phase 28 sites๐Ÿ“ Phoenix๐Ÿ“ Duarte๐Ÿ“ Irvine City of Hope Medical Center ยท Tests: Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomograโ€ฆ Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies NCT06879340Phase 11 site๐Ÿ“ Westwood University of Kansas Medical Center ยท Tests: DuoCAR20.19.22-D95, Fludarabine (Conditional therapy), Cyclophosphamide (Conditional therapy) CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies NCT05442515Phase 1, Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: CD19/CD22-CAR-transduced T cells, cyclophosphamide, fludarabine Co-administration of CART22-65s and huCART19 for B-ALL NCT05674175Phase 1, Phase 21 site๐Ÿ“ Philadelphia Stephan Grupp MD PhD ยท Tests: Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s), Autologous, humanized anti-CD19 CAR T cell therapy (huโ€ฆ Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL NCT06080191Phase 11 site๐Ÿ“ Rome Bambino Gesรน Hospital and Research Institute ยท Tests: CD19-CAR_Lenti_ALLO Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia NCT03739814Phase 2285 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Anchorage National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy, Inotuzumab Ozogamicin Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) NCT06395103Phase 1, Phase 271 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ New Haven Merck Sharp & Dohme LLC ยท Tests: Zilovertamab vedotin Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL NCT02393157Phase 21 site๐Ÿ“ Valhalla New York Medical College ยท Tests: Obinutuzumab, Liposomal ARA-C, Ifosfamide, Carboplatin, Etoposide
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy